ArticleFrontiers in medicine2026
Case Report: Chronic Morel-Lavallée lesion: dynamic MRI progression, histopathological findings and surgical treatment.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Morel-Lavallée lesion (MLL) is a closed soft tissue avulsion injury resulting from shear force trauma. Chronic Morel-Lavallée lesions present significant management challenges due to the formation of fibrous caps, persistent fluid accumulation, and a tendency for recurrence. Nevertheless, the pathogenesis and imaging characteristics of these lesions remain poorly understood. Methods: This study presents a case of a chronic Morel-Lavallée lesion located in the right hip, with a disease progression lasting over 10 years. The MRI characteristics of the lesion were compared across different stages. The patient underwent open resection of the lesion, along with excision of excess skin and subcutaneous tissue, followed by negative-pressure drainage surgery. The efficacy of the treatment was evaluated through a 1-year postoperative follow-up. Results: MRI examinations at different time points revealed a progression of the lesion from a chronic organized hematoma (Mellado-Bencardino classification Type III) to a coexistence of a chronic organized hematoma (Type III) and subacute hematoma-like lesions (Type II), indicating dynamic progression rather than static stability of the chronic Morel-Lavallée lesion. Characteristic MRI findings included hematoma organization, fibrous capsule formation, round fat globules or fat septa, and layered fluid distribution within the cyst. Open surgery achieved complete resection of the lesion along with excess skin and subcutaneous tissue, followed by negative-pressure drainage, resulting in excellent wound healing; no recurrence was observed during the one-year follow-up, and hip joint function remained normal. Conclusion: The chronic progression of Morel-Lavallée lesions is a dynamic process characterized by MRI findings such as fat globules or fat septa, fluid level stratification, hematoma organization, and capsule formation, all of which aid in definitive diagnosis. For large, recurrent chronic Morel-Lavallée lesions, open surgical resection of the lesion, along with the excision of excess skin and subcutaneous tissue, combined with adequate negative pressure drainage, effectively eliminates dead space and reduces the risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.